Assessment and certification of bioequivalent copies of innovative drug substances.
Development of certified mechanisms for the selection of the most appropriate medical treatment schema based on pharmacogenetics.
Development of a digital platform for health for the provision of personalized health services.
Development of the virtual physiological human.
Print this page